Claire Cenciarini-Borde
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Claire Cenciarini-Borde has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Bernard La Scola
Microbes Evolution Phylogeny and Infections (MEPHI), Aix-Marseille Université
1 shared publication - Sophie Courtois
Suez, CIRSEE, 38 rue du président Wilson, 78230, Le Pecq, France
1 shared publication
Latest Publications
- 11 February 2009
- Published by Taylor & Francis in Future Microbiology
- Vol. 4 (1) , 45-64
Nucleic Acids as Viability Markers for Bacteria Detection Using Molecular Tools
A large set of nucleic acid detection methods with good sensitivity and specificity are now available for the detection of pathogens in clinical, food and environmental samples. Given increasing demand, many efforts have been made to combine these methods to assess viability. Genomic DNA PCR amplification has been shown to be inappropriate for distinguishing viable from dead bacteria owing to DNA stability. Many authors have tried to bypass this difficulty by switching to RNA amplification methods such as reverse transcription-PCR and nucleic acid sequence-based amplification. More recently, researchers have developed methods combining specific sample pretreatment with nucleic acid detection methods, notably ethidium or propidium monoazide pretreatment coupled with PCR DNA detection or direct viable count methods and subsequent fluorescent in situ hybridization of 16S rRNA. This review evaluates the performance of these different methods for viability assessment.
- 11 February 2009
- Published by Taylor & Francis in Future Microbiology
- Vol. 4 (1) , 45-64
Nucleic Acids as Viability Markers for Bacteria Detection Using Molecular Tools
A large set of nucleic acid detection methods with good sensitivity and specificity are now available for the detection of pathogens in clinical, food and environmental samples. Given increasing demand, many efforts have been made to combine these methods to assess viability. Genomic DNA PCR amplification has been shown to be inappropriate for distinguishing viable from dead bacteria owing to DNA stability. Many authors have tried to bypass this difficulty by switching to RNA amplification methods such as reverse transcription-PCR and nucleic acid sequence-based amplification. More recently, researchers have developed methods combining specific sample pretreatment with nucleic acid detection methods, notably ethidium or propidium monoazide pretreatment coupled with PCR DNA detection or direct viable count methods and subsequent fluorescent in situ hybridization of 16S rRNA. This review evaluates the performance of these different methods for viability assessment.